トランスキャセター大動脈弁置換を受けた患者のマイクロRNA-21発現の臨床的意義と相関
Anat Berkovitch1, Zvi Sirotkin1, Yoni Grossman1
1Division of Cardiology, Leviev Cardiovascular & Thoracic Center, Chaim Sheba Medical Center, Tel Hashomer affiliated to School of Medicine, Tel-Aviv University, Tel Aviv, Israel.
American journal of physiology. Heart and circulatory physiology
|August 26, 2025
まとめ
トランスキャテータ性大動脈弁置換 (TAVR) の後の miR - 21 濃度の有意な低下は,主要な心血管不良および死亡のリスクが高いことを示しています. この発見は, miR-21を TAVR患者のアウトカムの潜在的なバイオマーカーとして強調しています.
科学分野:
- 心臓病科
- バイオマーカーの発見
- 分子診断
背景:
- トランスキャテーターによる大動脈弁置換 (TAVR) は重度の大動脈狭窄症に対する一般的な処置である.
- 心臓のバイオマーカーの上昇はTAVR後によく見られるが,その予後値については議論されている.
- マイクロRNA (miRNA) は,心臓血管疾患の病原性および潜在的なバイオマーカーとして重要な役割を果たしている.
研究 の 目的:
- TAVRを受けた患者の特定のmiRNAの予後的意義を調査する.
- 高リスク患者の分層化における miRNA の有用性を評価する.
- TAVR後の主要な心血管または脳血管疾患 (MACCE) と miRNAレベルを相関させる.
主な方法:
- トランスフェモラルTAVRを受ける患者の将来的な登録.
- 血液サンプル採取は,出血とTAVRの6時間後です.
- PCRによるmiR-21,miR-1,miR-210の定量化とΔΔCt法による相対定量化 (RQ)
- miRNAの相関性に対するMACCEの分析とROC曲線の分析.
主要な成果:
- 76人の患者 (平均年齢80. 8歳) を分析した. MACCEはほぼ4分の1に発生した.
- miR- 21 RQは,MACCEからの自由を予測する中程度の精度を示した (R=0. 61).
- miR-21値の有意な低下 (RQ < 0. 709) は,非有意な変化と比較して,より高いMACCE率 (40%対16%) と30日間の死亡率 (12%対0%) と関連していた.
結論:
- TAVRの6時間後のmiR-21値の有意な低下は,患者の不良の結果と関連しています.
- miR-21は,TAVR患者におけるリスク分層のバイオマーカーとして潜在的であることを示しています.
- パーソナライズされたTAVR後の管理戦略は,miR-21のモニタリングから利益を得ることができます.
さらに関連する動画
関連する概念動画
MicroRNAs
21.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
Mitral Valve Prolapse I: Introduction
42
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
42
Mitral Stenosis I: Introduction
34
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
34
Aortic Regurgitation I: Introduction
36
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36
Mitral Regurgitation I: Introduction
55
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
55
Mitral Stenosis II: Clinical features and Diagnostic Tests
37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37


